Webinar
Small Size, Big Plans – Product Development Advice for Small Companies
Now Available On-Demand | Rho

This webinar will provide advice on how to set your small company up for long-term success through the use of strategic development plans, purposeful outsourcing, patent protection, partnership strategies, and provide specific examples of success stories and lessons learned. Register now!

Webinar
Putting Patient-Centric Principles into Practice
Now Available On-Demand | Rho

Learn practical strategies for implementing patient-centered principles that engage patients without sacrificing research quality or adding untenable costs to your trials. During this webinar, experts will share how to design trials that honor patient needs and desires. Register Now!

Whitepaper
Transformation Initiatives Underway for Regulatory Information
Veeva

Transformation initiatives underway for Regulatory Information Management. Pharma is taking a more holistic approach to managing regulatory processes. Read how their efforts are paying off.  

Whitepaper
Considering an eTMF Solution? Industry Research Reveals the Top Benefits
Veeva

The largest survey of TMF owners reveals drivers and trends in improving inspection readiness and shortening trial time. Read more.

Whitepaper
Expert Advice: Designing Systems for Global Content Processes
Veeva

There are many reasons companies initiate process harmonization efforts: mergers and acquisitions, globalization, or the adoption of new technologies. 


This paper provides a dozen best practices for designing global systems that will help make process harmonization initiatives successful. Read it now.

Multimedia
FierceBiotech Radio on GSK's CEO shakeup, Lilly's Alzheimer's uncertainty, and Valeant's latest disaster
FierceBiotech Radio

FiercePharma's Eric Palmer and FierceBiotech's Damian Garde discuss the pending retirement of GlaxoSmithKline CEO Andrew Witty, Eli Lilly's bold decision with a big Alzheimer's trial and Valeant Pharmaceuticals' rough week.

Download the episode on iTunes or Stitcher, or listen here.

Multimedia
FierceBiotech Radio on the FDA's new boss, Sanofi's latest shortcut, and a little 'financial innovation'
FierceBiotech Radio

FiercePharma's Eric Palmer and FierceBiotech's Damian Garde discuss the confirmation of Robert Califf as the next FDA commissioner, Sanofi's efforts to undercut Novo Nordisk in diabetes, and a novel approach to regulating drug costs. Download the episode on iTunes or Stitcher, or listen here--and be sure to subscribe

Multimedia
Pharma's TV blitz, biotech's IPO trickle, and the M&A future of Intercept Pharmaceuticals
Catalent

FiercePharma's Eric Palmer and FierceBiotech's Damian Garde discuss the rise of TV ads for specialty drugs, signs of life in the biotech IPO scene, and the case for Intercept Pharmaceuticals as a buyout target.  Download the episode on iTunes or Stitcher, or listen here--and be sure to subscribe.

Multimedia
Pharma's day on the Hill, biotech's paucity of M&A, and the gathering storm of biosimilars
FierceBiotech Radio

FiercePharma's Eric Palmer and FierceBiotech's Damian Garde discuss a bizarre congressional hearing, how biotech's slump affects the buyout climate, and a major development in the world of biosimilars.

Download the episode on iTunes or Stitcher, or listen here--and be sure to subscribe. Let us know what you think by dropping a line to [email protected]

Multimedia
Gilead's wide-open future, biotech's long winter, and Sanofi's ongoing makeover
FierceBiotech Radio

FiercePharma's Eric Palmer and FierceBiotech's Damian Garde discuss the future of Gilead Sciences, biotech's continued slump on Wall Street, and the latest move in Sanofi's efforts to right the ship.

Download the episode on iTunes or Stitcher, or listen here--and be sure to subscribe. Let us know what you think by dropping a line to [email protected]